Trial intelligence / Profile preview

Dexmedetomidine effect on the analgesic ED50 of ropivacaine for ultrasound-guided transversus abdominis plane block

ChiCTR2000032991Phase 4Recruiting

Sponsor
North Sichuan Medical College
Start
May 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ropivacaine and dexmedetomidine in postoperative pain (2 arms), sponsored by North Sichuan Medical College. Primary endpoint: VAS score. Started May 2020; status: recruiting.

02

Drugs

ropivacainedexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR2000032991.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000032991.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call